证券记录 · 已归档季度
MDT
Medtronic plc · Healthcare · Medical - Devices
25被追踪持有人
-2Δ持有人
519.60M持有股份
$49.51B报告持仓市值
+0新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -7.4% ·
股份流向 -0.8% ·
净新建仓位 -12.0%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.44M | $115.59M | n/a | −2 |
| Q2 2026 | 172 | +1 | 851.51M | $67.87B | +6 | −7 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | n/a |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | n/a | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | n/a |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | n/a | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | n/a |
| Q2 2024 | 20 | n/a | 97.49M | $7.67B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 127.07M | +0.1% | $12.10B | 0.2% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 119.57M | -2.4% | $11.39B | 0.2% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 104.39M | n/a | $9.94B | 0.3% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (被动) | 60.46M | +1.1% | $5.80B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 27.65M | -2.0% | $2.62B | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 20.23M | n/a | $1.93B | 0.1% | n/c | 1 | SEC ↗ ×20 |
| 7 | Wellington Management ✦ | 10.19M | +35.3% | $970.46M | 0.2% | ▲ Add | 6 | SEC ↗ ×8 |
| 8 | Goldman Sachs Group ✦ | 8.16M | n/a | $777.61M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 9 | Dodge & Cox ✦ | 7.73M | -0.2% | $735.74M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 10 | Capital World Investors ✦ | 6.58M | +19.2% | $626.58M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 5.92M | -2.0% | $564.17M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 4.81M | +19.5% | $457.92M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 3.70M | -62.2% | $352.53M | 0.3% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 3.33M | +68.3% | $314.40M | 0.2% | ▲ Add | 6 | SEC ↗ ×7 |
| 15 | Arrowstreet Capital ✦ | 2.43M | +62.6% | $231.50M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 2.37M | +46.0% | $225.51M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 17 | Adage Capital Partners ✦ | 2.18M | +20.8% | $207.67M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 1.05M | -56.1% | $100.27M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 478.21K | -3.0% | $45.55M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 20 | Bridgewater Associates ✦ | 338.20K | +67.3% | $32.21M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 288.01K | +11.7% | $27.43M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 239.53K | -12.6% | $22.81M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 217.24K | -74.8% | $20.69M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Marshall Wace ✦ | 209.77K | +30.8% | $19.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 25 | PRIMECAP Management ✦ | 3.82K | -99.2% | $363,818 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $1.43B | 曾为 0.2% |
| Renaissance Technologies | $37.70M | 曾为 0.1% |
| Point72 Asset Management | $27.95M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 2,204 持有人, 1.04B 股份, $87.65B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
Marinaro Michael
Officer · 10.42K 股 · $1.00M
Oct 15
Martha Geoffrey
Officer, Director · 50.00K 股 · $4.75M
Sep 16
KIIL HARRY SKIP
Officer · 1.48K 股 · $138,883
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据